Abiopharma

🔍 Mendez Echevarria Maria Cristina (Executive)

Company: Otis Worldwide Corp (OTIS)

Report Date: 2026-08-23

Detailed Transactions and Holdings:

• Acquired 2,137 shares of Common Stock (Direct)
  Date: 2026-08-23 | Code: M | equity_swap_involved: 0 | shares_owned_after: 11,394.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 838 shares of Common Stock at $71.49 per share (Direct)
  Date: 2026-08-23 | Code: F | equity_swap_involved: 0 | shares_owned_after: 10,556.00 | transaction_form_type: 4
• Sold 2,137 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-23 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,145.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Restricted stock units (RSUs) convert into common stock on a one-for-one basis. RSUs include the right to receive dividend equivalents that are credited as additional RSUs.
• F2: On August 23, 2024, the reporting person was granted RSUs vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. The second installment vested on the Transaction Date.